arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Friday 23 September

Please find below the programme schedule for Thursday 23 September 2022.

Friday 23 Sep

Meet the experts session 2

M2.1 Point of care test

Cornelia Lass Flörl, Austria and Martin Hönigl, Austria

08:00

M2.2 Allergic fungal lung diseases

Ritesh Agarwal, India and Koichiro Asano, Japan

09:00

Key note (P6) New azoles in management of invasive mould infections

Johan Maertens, Belgium

Parallel session 7

Parallel session 7 will take place from 10:30 hrs. until 12:00 hrs. and consists of five symposia.

S7.1 Update in management of fungal infection in adult haematology

Chair: Xiao-Jun Huang, China

10:30

S7.1a Update in prophylaxis

Livio Pagano, Italy

10:50

S7.1b Breakthrough fungal infection

Dinesh Bhurani, India

11:10

S7.1c New treatment options for management of fungal infections

Johan Maertens, Belgium

11:30

S7.1d Reliability of bedside point-of-care tests for C. neoformans, M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study

Aude Sturny Leclere, France

11:45

Q&A with all speakers

S7.2 More than just candidemia: Clinical aspects, diagnosis and treatment, and pathogenesis of deep- seated candidiasis

Chair: TBD

10:30

S7.2a Non- bloodstream deep-seated candidiasis: Clinical spectrum of disease, epidemiology and antifungal resistance

M. Hong Nguyen, USA

10:50

S7.2b Advances in the diagnosis, treatment and prevention of deep-seated candidiasis

Ram Gopalakrishnan, India

11:10

S7.2c Candida- host interactions and pathogenesis of deep-seated candidiasis, and lessons for patient management

Rajeev Soman, India

11:30

S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis

Xiaodong She, China

11:45

Q&A with all speakers

S7.3 Emergent theories on pathogenic fungal dispersal around the globe

Chair: Jianping Xu, Canada

10:30

S7.3a Emergence and dispersal of Coccidioides in the Western Hemisphere

David Engelthaler, USA

10:50

S7.3b Niche and dispersal of Candida auris

Wieland Meyer, Australia

11:10

S7.3c Evolution of Pseudogymnoascus destructans, the cause of white nose syndrome in bats

Jianping Xu, Canada

11:30

S7.3d Environmental Surveillance of Aspergillus fumigatus in Dutch agricultural crops

Jianhua Zhang, Netherlands

11:45

Q&A with all speakers

S7.4 Pathgenesis and host defense

Chairs: Shibuya Kazutoshi, Japan and Shigeru Kohno, Japan

10:30

S7.4a Vaccine-inducing lung resident CD4+ memory T cells are protective against Cryptococcus gattii infections

Keigo Ueno, Japan

10:50

S7.4b Microaerobic conditions enhance fungal pathogenesis in Candida spp.

Yoshitsugu Miyazaki, Japan

11:10

S7.4c The hidden pathophysiology behind the images of invasive fungal infections

Kazutoshi Shibuya, Japan

11:30

S7.4d Candida albicans SR-like protein kinases regulate different cellular processes: Sky1 is involved in control of ion homeostasis, while Sky2 is important for dipeptide utilization

Philipp Brandt, Germany

11:45

Q&A with all speakers

S7.5 Late breaking abstracts

TBD

12:00

Lunch and poster session 3

12:30

Pipeline lunch session

Key note (P7): Banging our head against the (fungal) wall

Neil Gow, UK

Parallel sessions 8

Parallel session 8 will take place from 15:00 hrs. until 16:30 hrs. and consists of five symposia.

S8.1 Tackling Candida auris in resource-limited settings

Chairs: Nelesh Govender, South-Africa and Methee Chayakulkeeree, Thailand

15:00

S8.1a Something along the lines of “A global update on Candida auris’

Tom Chiller, USA

15:20

S8.1b Emergence and establishment of C. auris in Indian hospitals

Anuradha Chowdhary, India

15:40

S8.1c Is a search and destroy strategy still feasible for Candida auris in South Africa?

Nelesh Govender, South-Africa

16:00

S8.1d Innovative approaches to tackle C. auris in Latin America

Arnaldo Lopes Colombo, Brazil

16:15

Q&A with all speakers

S8.2 What is new in pediatric mycology?

Chair: Emmanuel Roilides, Greece

15:00

S8.2a Trends in epidemiology of pediatric Candida infections worldwide

Emmanuel Roilides, Greece

15:20

S8.2b Aspergillus spp. in primary immunodeficiencies and cystic fibrosis

Adilia Warris, UK

15:40

S8.2c Updated guidelines in the management invasive fungal infections in paediatrics

Andreas Groll, Germany

16:00

S8.2d Fungal beta-glucans and mannan performances in HIV-associated histoplasmosis

Antoine Adenis, France

16:15

Q&A with all speakers

S8.3 How the Fungal Cell Wall Glycan Can Modulate the Immune Response?

Chair: Boualem Sendid, France

15:00

S8.3a Structural aspects

TBD

15:20

S8.3b How Fungal Cell Wall Glycans Modulate the Activation of Platelets?

Samir Jawhara, France

15:40

S8.3c Cell wall glycans as targets for the development of new antifungals

Vishukumar Aimanianda, France

16:00

S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: role in pathogenicity

Rupinder Kaur, India

16:15

Q&A with all speakers

S8.4 Veterinary Mycology and One Health Working Group Business Meeting

Chairs : Jacques Guillot, France and Amir Seyedmousavi, USA

S8.5 Genotyping of Cryptococcus neoformans and C. gattii

Chairs: Wieland Meyer, Australia and Carolina Firacative, Colombia

15:00

S8.5a The global MLST database and it use in characterising the population structure of the Cryptococcus neoformans and C. gattii species complexes

Wieland Meyer, Australia

15:20

S8.5b Molecular Epidemiology of the C. neoformans and C. gattii species complexes in India

Ferry Hagen, Netherlands

15:40

S8.5c MLST Genotyping and phylogenetics of AD-hybrids

Massimo Cogliati, Italy

16:00

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations

Carolina Firacative, Colombia

16:15

Q&A with all speakers

16:30

Break

Parallel session 9

Parallel session 9 will take place from 16:45 hrs. until 18:15 hrs. and consists of five symposia.

S9.1 Chronic Pulmonary Aspergillosis - where do we stand?

Chair: Aleksandra Barac, Serbia

16:45

S9.1a Diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis

Malcolm Ricardson, UK

17:05

S9.1b Clinical presentations and complications of chronic pulmonary aspergillosis

Aleksandra Barac, Serbia

17:25

S9.1c Current treatment options for CPA and future directions

David Denning, UK

17:45

S9.1d Chronic pulmonary aspergillosis in post-tb and retreatment tb patients in Lagos, Nigeria

Adeyinka Davies, Nigeria

18:00

Q&A with all speakers

S9.2 Azole resistance in Aspergillus fumiagatus: how hot is your hotspot?

Jianhua Zhang, Netherlands and Paul Verweij, Netherlands

16:45

S9.2a Hotspots of AMR in A. fumigatus; sex, drugs & (re) evolution

Jianhua Zhang, Netherlands

17:05

S9.2b Hot and Cold: the expanding distribution of triazole-resistance in Aspergillus fumigatus

Jianping Xu, UK

17:25

S9.2c A genomic approach to unravel the origin & spread of azole-resistant A. fumigatus

TBD

17:45

S9.2d Directed evolution of voriconazole resistance in Aspergillus fumigatus identifies novel mutations responsible for triazole resistance

Nir Osherov, Israel

18:00

Q&A with all speakers

S9.3 Drug resistance in emerging pathogenic fungi

Chairs: Rajendra Prasad, India and Kaustuv Sanyal, India

16:45

S9.3a Antifungal resistance in emerging Candida auris

Jeffrey Rybak, Germany

17:05

S9.3b Fighting drug resistance with immunotherapies: Update on the Candida vaccine project

Ashraf Ibrahim, USA

17:25

S9.3c Antifungal drug resistance in clinical isolates of Candida spp: behind the curtains

Dominique Sanglard, France

17:45

S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria

Raghav Vij, Germany

S9.4 Free oral paper session

Chair: TBD

16:45

S9.4a TBD

17:05

S9.4b TBD

17:25

S9.4c TBD

17:45

S9.4d TBD

18:00

Q&A with all speakers

S9.5 Malassezia: pathogenesis and disease

Chair: Thomas Dawson, Singapore

16:45

S9.5a Role of Malassezia in Crohns disease and IBD

TBD

17:05

S9.5b The need for longitudinal testing in human disease

TBD

17:25

S9.5c Malassezia/Host interactions and the Il-17/23 axis

Salomé LeibundGut- Landmann, Switzerland

17:45

S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients

Prasanna Honnavar, Canada

18:00

Q&A with all speakers

19:30

Congress dinner